Answers are grounded in this paper and cite their sources.
To realize continuous integrated manufacturing of biopharmaceuticals, all steps of production have to be operated in a continuous mode. Virus inactivation is a crucial step in this process, and due to standard procedures and a fixed residence time, it is particularly challenging to realize. Two articles in this issue present possible solutions to this problem.
No takes yet. Share an insight, caveat, or question.
Alois Jungbauer (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: